Scilex Holding (SCLXW) Operating Expenses (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Operating Expenses of $40.8 million in Q1 2026, down 64.81% quarter-over-quarter from $115.9 million in Q4 2025, and up 23.95% on a YoY basis from $32.9 million in Q1 2025.

Scilex Holding (SCLXW) Operating Expenses (2020 - 2026) Analysis & Trends

Scilex Holding's Operating Expenses history runs 7 years deep, the most recent figure standing at $40.8 million for Q1 2026.

  • In Q1 2026, Operating Expenses rose 23.95% year-over-year to $40.8 million; the TTM figure through Mar 2026 stood at $384.1 million (up 169.52% YoY), while the FY2025 annual figure was $376.3 million, up 168.78% from the prior year.
  • Operating Expenses was $40.8 million for Q1 2026 at Scilex Holding, down from $115.9 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $197.1 million in Q3 2025 to a low of $15.6 million in Q1 2022.
  • Historically, Operating Expenses has averaged $46.9 million across 5 years, with a median of $32.9 million in 2025.
  • Biggest YoY gain for Operating Expenses was 11168.15% in 2022; the steepest drop was 52.42% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $31.7 million in 2022, then gained by 0.45% to $31.8 million in 2023, then surged by 36.09% to $43.3 million in 2024, then jumped by 167.76% to $115.9 million in 2025, then slumped by 64.81% to $40.8 million in 2026.
  • The last three Operating Expenses figures came in at $40.8 million (Q1 2026), $115.9 million (Q4 2025), and $197.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -5.14 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 6.72 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 9.59 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 11.01 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 19.82 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 5.95 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 4.37 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 5.50 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 8.25 Bn
10 Scilex Holding - - 4.15 Mn 40.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 40.78 Mn
Dec 31, 2025 115.88 Mn
Sep 30, 2025 197.07 Mn
Jun 30, 2025 30.40 Mn
Mar 31, 2025 32.90 Mn
Dec 31, 2024 43.28 Mn
Sep 30, 2024 34.35 Mn
Jun 30, 2024 31.99 Mn
Mar 31, 2024 30.36 Mn
Dec 31, 2023 31.80 Mn
Sep 30, 2023 48.92 Mn
Jun 30, 2023 35.40 Mn
Mar 31, 2023 36.06 Mn
Dec 31, 2022 31.66 Mn
Sep 30, 2022 21.99 Mn
Jun 30, 2022 19.40 Mn
Mar 31, 2022 15.62 Mn
Dec 31, 2021 66.53 Mn
Sep 30, 2021 283,346.00
Jun 30, 2021 172,140.00